Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma

被引：0
|
作者：
Johnson, M. L.
Sima, C.
Paik, P. K.
Janjigian, Y. Y.
Pao, W.
Kris, M. G.
Ladanyi, M.
Riely, G. J.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7541
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7541
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and KRAS mutation
    Yang, Shifeng
    Yu, Xinmin
    Fan, Yun
    Shi, Xun
    Jin, Ying
    [J]. JOURNAL OF CANCER, 2018, 9 (16): : 2930 - 2937
  • [22] Prognostic Impact of EGFR and KRAS Mutations in Patients with Lung Adenocarcinoma Treated with Definitive Radiation Therapy
    Oro, Federica
    Sonnick, Mark
    Wang, Hongyun
    Zakowski, Maureen
    Wu, Abraham J.
    Chaff, Jamie E.
    Paik, Paul
    Tsang, Mazie
    Hsu, Meier
    Rosenzweig, Kenneth
    Zhang, Zhigang
    Rimner, Andreas
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S576 - S576
  • [23] EGFR AND KRAS MUTATIONS IN PATIENTS HAVING LUNG ADENOCARCINOMA ASSOCIATED WITH HUMAN PAPILLOMA VIRUS INFECTION
    Cardona, Andres F.
    Rosell, Rafael
    Vargas, Carlos
    Carranza, Hernan
    Archila, Pilar
    Otero, Jorge M.
    Rodriguez, July Katherine
    Arrieta, Oscar
    Martin, Claudio
    Mas, Luis
    Corrales-Rodriguez, Luis
    Bramuglia, Guillermo
    Cuello, Mauricio
    Pastran, Zulay
    Curcio, Elizabeth
    Rojas, Leonardo
    Bernal, Laura
    Giannikopoulos, Petros
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S428 - S428
  • [24] Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma
    Laidlaw, Grace
    Gao, Rebecca
    Ayers, Kelsey
    Backhus, Leah
    Berry, Mark
    Shrager, Joseph
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S751 - S751
  • [25] Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma
    Zhou, Xiuzhi
    Cai, Li
    Liu, Junjie
    Hua, Xiaomin
    Zhang, Ying
    Zhao, Huilin
    Wang, Bin
    Li, Boqing
    Gai, Pengzhou
    [J]. ONCOLOGY LETTERS, 2018, 16 (01) : 362 - 370
  • [26] KRAS mutations in 1355 Italian patients with lung adenocarcinoma
    Paliogiannis, P.
    Lobrano, R.
    Colombino, M.
    Sini, M. C.
    Fara, A.
    Fedeli, M. A.
    Palmieri, G.
    Cossu, A.
    [J]. VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S141 - S142
  • [27] Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib
    Zhang, Li
    Yuan, Xianglin
    Chen, Yuan
    Du, Xiao-Juan
    Yu, Shiying
    Yang, Ming
    [J]. GENE, 2013, 517 (01) : 60 - 64
  • [28] Survival in EGFR Mutated Advanced Lung Cancer Adenocarcinoma Patients - A National Study
    Jakobsen, Erik
    Iachina, Maria
    Olsen, Karen Ege
    Green, Anders
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1223 - S1224
  • [29] Concurrent EGFR and KRAS Mutations in Lung Adenocarcinoma: A Single Institution Case Series
    Schwartz, C.
    Khan, M.
    Nguyen, R.
    Pasquinelli, M.
    Feldman, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S600 - S601
  • [30] Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas
    Sonobe, Makoto
    Kobayashi, Masashi
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Nakayama, Ei
    Takahashi, Tsuyoshi
    Menju, Toshi
    Takenaka, Kazumasa
    Miyahara, Ryo
    Huang, Cheng-Long
    Okubo, Kenichi
    Bando, Toru
    Date, Hiroshi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S347 - S354
12345